Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Tri Locum Partners LP
Form 13F · Q2 2026

Tri Locum Partners LP

CIK 1826434Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$813M
Reported book value
19
Positions
12
Quarters on record
Top 50
Positions

Tri Locum Partners LP — holdings

Top 19 positions of 19, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1JNJ Johnson & Johnson424,945+2.5%$108M13.3%
2VERTEX PHARMACEUTICALS INC Vertex Pharmaceuticals Inc201,791+56.0%$100M12.3%
3LLY Eli Lilly & Co76,532+23.8%$92M11.3%
4ASND Ascendis Pharma A/S258,740—$69M8.5%
5DXCM Dexcom Inc820,479+17.5%$55M6.8%
6AXSM Axsome Therapeutics Inc.219,308+253.1%$54M6.6%
7JAZZ Jazz Pharmaceuticals Plc221,720+39.7%$53M6.6%
8ELVN Enliven Therapeutics Inc866,716—$44M5.4%
9ARGX Argenx Se41,596+31.5%$39M4.7%
10MDGL Madrigal Pharmaceuticals Inc68,273−33.9%$37M4.5%
11RVMD Revolution Medicines Inc151,822—$28M3.5%
12UTHR United Therapeutics Corp Del47,026−33.2%$25M3.1%
13TEVA PHARMACEUTICAL INDS LTD Teva Pharmaceutical Inds Ltd746,835−26.9%$25M3.1%
14TARS Tarsus Pharmaceuticals Inc328,340+30.0%$21M2.5%
15ISRG Intuitive Surgical Inc47,983−68.7%$19M2.3%
16CYTK Cytokinetics Inc194,000—$17M2.0%
17DNTH Dianthus Therapeutics Inc120,712−17.1%$12M1.4%
18BBNX Beta Bionics Inc493,344—$8M1.0%
19DFTX Definium Therapeutics Inc162,996−55.9%$8M0.9%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.